Boston Scientific's WATCHMAN FLX Pro sits invisibly inside the heart, yet it promises something very tangible for many atrial fibrillation patients - protection from stroke without a lifetime on blood ...

Boston Scientific has shared a duo of positive data readouts from two separate trials evaluating its Watchman FLX left atrial appendage closure (LAAC) device in non-valvular atrial fibrillation (AF) ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Boston Scientific confirmed investors' worst fears Wednesday by cutting 2026 guidance for the second time this year. “This update today is not the outcome we planned or what you have come to expect ...

Boston Scientific has secured label expansion from FDA for its Watchman FLX and Watchman FLX Pro. The Marlborough, MA-based company had already expected the label expansion, which now includes ...

Boston Scientific cut its full-year outlook after two of its core heart-disease products faced unexpected challenges in the second quarter. Revenue from the Watchman heart implant, which is used to ...